September 30, 2016 3:29 PM ET

Biotechnology

Company Overview of KaloBios Pharmaceuticals, Inc.

Executive Profile

Dean Witter III

Interim Chief Financial Officer, KaloBios Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 5 different industries.

69--

Background

Mr. Dean Witter, III, also known as Kip, has been an Interim Chief Financial Officer of KaloBios Pharmaceuticals, Inc. since January 7, 2016. Mr. Witter has been Vice President of Interim Finance & Accounting Group of The Brenner Group, Inc. since January 2009. He serves as President of The Dean Witter Foundation. He served as the Chief Financial Officer, Secretary and Principal Accounting Officer of Unwired Planet, Inc. from March 12, 2015 to November 2, 2015. He served ...

Corporate Headquarters

1000 Marina Boulevard
Brisbane, California 94005

United States

Phone: 650-243-3100
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

MBA
Stanford Graduate School of Business
BA
Harvard College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KaloBios Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.